Theramer^® Technology

Rimon Therapeutics is the Theramer^® Company. Theramers^® are medical polymers that have biological activity in and of themselves, without the use of drugs.

Theramers^® provide:

• Drug-like activities
• Device timelines
• Versatile chemistry

Core Theramer^® Technologies:

• MI Theramer^®: inhibits the activity of matrix metalloproteases (MMPs), a ubiquitous group of enzymes that are implicated in many conditions in which tissue is weakened or destroyed
• AM Theramer^®: a thermoplastic that kills gram +ve and gram -ve bacteria without harming mammalian cells
• Angiogenic Theramer^®: induces new blood vessel development (angiogenesis) in wounds or other ischemic tissue
• ThermaGel^®: a polymer that changes from a liquid to a strong gel reversibly around body temperature

"The Promise of Theramers^® - The interesting thing is that Theramers^® are medical polymers or plastics that have a therapeutic activity. Typically, medical polymers have been used for their physical or mechanical properties. Now they can be exploited to additionally possess a drug-like activity to promote a healing response. Theramers^® allow patients to avoid the use of soluble drugs that can cause side effects when they are administered systemically and distributed throughout the body. Additionally, the materials are less costly to produce compared to pharmaceutical therapeutics. Rimon's key products benefit from the shorter timelines, and therefore reduced developmental costs, compared to those of pharmaceutical products."
Gary Skarja, PhD, Director, R&D